Found 28 matching trials
A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Recurrent or Metastatic Cervical Cancer PHASE2 This study is a single-arm, multicenter, Phase II study to evaluate the eff...
Show More Location
Harbin Medical University Cancer Hospital
Learn More & Join Trial
A Phase Ib/II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Patients With Advanced/Metastatic Solid Tumors PHASE1 The study is being conducted to explore the reasonable dosage and evaluate ...
Show More Location
Hunan Provincial Cancer Hospital
Learn More & Join Trial
Neoadjuvant Chemoradiotherapy Combined With Immunotherapy and Anti-angiogenesis in Treating Locally Advanced Rectal Cancer PHASE2 This is a multicenter, prospective, randomized phase II trial designed to e...
Show More Location
Department of Colorectal Surgery in Changhai Hospital
Learn More & Join Trial
PD-1 Inhibitor Intraperitoneal Perfusion Combined With PRaG Therapy for Malignant Ascites PHASE1 The effect and safety of intraperitoneal infusion of PD-1 inhibitor is uncl...
Show More Location
Multiple Locations
Learn More & Join Trial
NCT + PD1 + Ketogenic Diet and/or Vitamin C for LARC PHASE2 To explore the efficacy and safety of adding a ketogenic diet and/or high-d...
Show More Location
Sixth Affiliated Hospital, Sun Yat-sen University
Learn More & Join Trial
Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC PHASE2 This is a Phase II, single arm, multicenter study designed to evaluate the ...
Show More Status
Active Not Recruiting
Location
Chongqing University cancer hospital
Learn More & Join Trial
Sequential AG and mFOLFOX Combined With Serplulimab Injection and Bevacizumab Injection in Untreated Advanced Pancreatic Cancer PHASE2 It is a single arm, open-label, multicenter, phase II cinical trial to eval...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors PHASE1 A total of 17 to 23 participants are anticipated to be enrolled in the Phas...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer PHASE2 This study aims to evaluate the safety and effectiveness of a combination t...
Show More Location
Chongqing University Cancer Hospital
Learn More & Join Trial
Efficacy and Safety of Serplulimab in Combination With Bevacizumab and FOLFIRINOX or NALIRIFOX as Second-Line Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma PHASE2 This is an investigator-initiated, open-label, single-arm, phase II trial e...
Show More Location
Shanghai General Hospital
Learn More & Join Trial